Related Experiment Video
Updated: Jun 15, 2026

Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans
Published on: July 21, 2023
Vitamin D and cardiovascular disease: a novel agent for reducing cardiovascular risk?
Panagiotis Anagnostis1, Vasilios G Athyros, Fotini Adamidou
1Endocrinology Clinic, Hippokration Hospital, Thessaloniki, Greece. anagnwstis.pan@yahoo.gr
Insights
Vitamin D deficiency is linked to cardiovascular disease (CVD) risk. This review examines vitamin D
Area of Science:
- Endocrinology
- Cardiology
- Nutritional Science
Background:
- Vitamin D deficiency is a known cause of bone disease.
- Emerging evidence suggests vitamin D influences numerous human physiological functions.
- Epidemiological studies link vitamin D deficiency to increased cardiovascular disease (CVD) prevalence.
Purpose of the Study:
- To review current data on the role of vitamin D deficiency in CVD development.
- To analyze the impact of vitamin D supplementation on cardiovascular outcomes.
Main Methods:
- Literature review of epidemiological studies.
- Analysis of research on vitamin D's role in cardiometabolic risk factors.
- Examination of studies on vitamin D supplementation and CVD.
Main Results:
- Vitamin D deficiency is associated with hypertension, diabetes, dyslipidemia, and metabolic syndrome.
- Vitamin D deficiency is implicated in the progression of atherosclerosis.
- Data on the effect of vitamin D supplementation on cardiovascular outcomes are under review.
Conclusions:
- Vitamin D deficiency is a significant factor in cardiovascular disease development.
- Further research is needed to clarify the benefits of vitamin D supplementation for cardiovascular health.
Abstract:
Vitamin D deficiency is a well-established risk factor for bone disease. Emerging data suggest a pleiotropic role of this agent in a variety of functions in humans. Epidemiological studies indicate an inverse association between vitamin D deficiency and the prevalence of cardiovascular disease (CVD), as well as individual cardiometabolic risk factors, such as hypertension, diabetes, dyslipidemia and the metabolic syndrome. Moreover, vitamin D deficiency has been implicated in the atherosclerotic process. This review considers current data regarding the role of vitamin D deficiency in the development of CVD and addresses the effect of supplementation on cardiovascular outcomes.
Related Concept Videos
Atherosclerosis III: Management
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Coronary Artery Disease IV: Preventive Measures
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
